about
Consequences of repeated blood-brain barrier disruption in football playersSignificance of MDR1 and multiple drug resistance in refractory human epileptic brainPathophysiological implications of neurovascular P450 in brain disordersBlood-brain barrier, bulk flow, and interstitial clearance in epilepsyEvidence for Status Epilepticus and Pro-Inflammatory Changes after Intranasal Kainic Acid Administration in MiceSerum S100B: a potential biomarker for suicidality in adolescents?Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesionsProApolipoprotein A1: a serum marker of brain metastases in lung cancer patientsBlood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity.Antagonism of peripheral inflammation reduces the severity of status epilepticus.Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approachesSmall vessel ischemic disease of the brain and brain metastases in lung cancer patients.Multimodal investigations of trans-endothelial cell trafficking under condition of disrupted blood-brain barrier integrity.Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkersIs peripheral immunity regulated by blood-brain barrier permeability changes?The role of shear stress in Blood-Brain Barrier endothelial physiologySeizure-promoting effect of blood-brain barrier disruption.Redistribution of PDGFRβ cells and NG2DsRed pericytes at the cerebrovasculature after status epilepticusPeripheral markers of blood-brain barrier damage.Cellular localization and functional significance of CYP3A4 in the human epileptic brain.Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hitsEffect of status epilepticus and antiepileptic drugs on CYP2E1 brain expressionCerebrovascular heterogeneity and neuronal excitability.Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures.Combined effects of prenatal inhibition of vasculogenesis and neurogenesis on rat brain development.Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations.In vivo and in vitro effects of pilocarpine: relevance to ictogenesis.Management of the patient with medically refractory epilepsy.Transporters in drug-refractory epilepsy: clinical significance.A pro-convulsive carbamazepine metabolite: quinolinic acid in drug resistant epileptic human brain.Overexpression of pregnane X and glucocorticoid receptors and the regulation of cytochrome P450 in human epileptic brain endothelial cells.Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases.Cerebrovascular remodeling and epilepsyA role for inflammation in status epilepticus is revealed by a review of current therapeutic approaches.Inflammatory pathways of seizure disorders.Selective and persistent upregulation of mdr1b mRNA and P-glycoprotein in the parahippocampal cortex of chronic epileptic rats.Blood-brain barrier damage and brain penetration of antiepileptic drugs: role of serum proteins and brain edema.Pattern of P450 expression at the human blood-brain barrier: roles of epileptic condition and laminar flowCerebrovascular pathology during the progression of experimental Alzheimer's disease.The blood-brain barrier hypothesis in drug resistant epilepsy.
P50
Q21133671-BA5D9495-A759-4F93-B827-128E31E01388Q24804381-2EB3DF32-8D38-4A5E-8775-FDD8DA5ABB48Q26745632-E9BCB870-7049-49A5-8A91-93B87027EA51Q28086846-8B80B110-EBC0-4EEB-8914-05650893EA40Q28550698-67BD817F-87C6-4AAF-B302-6D368661AA72Q28751578-894224C8-475A-4C92-A2B3-198B3BF8BCBAQ30432850-9D531270-ABB9-4518-A1F2-DC73EEB20B83Q30485388-5F97B4D0-FFCE-4B34-82DD-FCB556AD42ACQ30496421-5CAAAB99-6229-4B93-9FE7-E04394F341E5Q30498265-5132FBA9-4494-491A-AF3C-1A680493A16BQ33354141-FA241139-0AB0-4CEE-B701-CB940C717B95Q33507517-3809881B-3B5B-483A-A5AF-734AD79B65ECQ33538891-74D4F70A-7860-4BC8-A6D1-9B5C90250B29Q33595790-FB61E3EB-9465-4B26-8AEF-3BC0354C6859Q33838466-88CA54ED-89F2-4801-91FE-24B46E0A8E9EQ33898503-6EB24679-352E-48DD-983A-390B624018CFQ34056074-62BE2380-3A1B-4F35-A3DC-EB45A30E2002Q34266638-CA7845E6-A4E2-4056-9838-76CD2D52E525Q34306491-68B13C8B-0349-4AA6-91B6-566EF635CA3AQ34669448-C18DAD35-6779-4136-9F3A-593F925BBF50Q35164692-B1DDD013-EF7D-481C-AD53-524F6E9808DEQ35252029-C8BB539E-599A-4423-AC67-5AB2CB0E669EQ36249615-4DAA9A24-D831-4948-9D67-C053344A5F25Q37058086-E0994FDD-8D63-44ED-8EB3-E4557A388457Q37509233-9B4CA77B-2318-46AD-8089-D69AC5811F4FQ37509237-B703BA1E-AED8-49AF-8553-EDC8627B4212Q37509243-952B7CC4-8348-49BC-9E82-6EDF4C3F10FDQ37642003-C9A02466-6397-4F5F-A4DF-E7B05D746B58Q37658263-8B338816-6648-4593-B7B3-4D0BC82689B9Q37727201-D9D299C4-6567-4150-BCAE-E94720C9D323Q37746377-FC7BF829-9BA8-4821-A960-7E783311FF2EQ37875183-93DB4F8B-1B52-42D0-8E95-8664A569B171Q38052687-A01F457A-CE38-420E-8200-9A662E9FBE67Q38133828-7F2C7ED8-16E4-412C-B626-AA2C978C37C3Q38172740-BCE9BFE3-457F-4D73-B012-BAB63315D718Q38336390-5D91BA69-E09A-4857-AA92-742F948C07C1Q38357037-7451EB4E-B36D-4363-A72E-3F2255F43CBDQ39752034-8795A4F8-A848-485E-AA4D-648F45F0E419Q42487571-9AD14390-693D-44E1-B698-B483BA269D24Q42546564-FEF0AF79-2C6F-40DF-BD64-DAC2D197F831
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicola Marchi
@ast
Nicola Marchi
@en
Nicola Marchi
@es
Nicola Marchi
@nl
Nicola Marchi
@sl
type
label
Nicola Marchi
@ast
Nicola Marchi
@en
Nicola Marchi
@es
Nicola Marchi
@nl
Nicola Marchi
@sl
prefLabel
Nicola Marchi
@ast
Nicola Marchi
@en
Nicola Marchi
@es
Nicola Marchi
@nl
Nicola Marchi
@sl
P1053
J-8607-2016
P106
P1153
6603811210
P21
P31
P3829
P496
0000-0001-9124-0226